Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Industry Provider Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
Events
Newsletters
JobWatch
White Papers
Patient Education
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» FDA Actions
Looking to read the full article? Subscribe today!
FDA Actions
September 1, 2020
New FDA Actions from ANA Therapeutics, Carisma Therapeutics and Kahr Medical.
Upcoming Events
23
Sep
Data Integrity in the COVID-19 Era and Beyond — Part II: Key Issues in Data Integrity: Today and Tomorrow
23
Sep
Diversifying Clinical Trial Participation: Effective Strategies for Identifying and Recruiting Diverse Patient Participants
17
Nov
15th Annual FDA Inspections vSummit
Featured Products
Regenerative Medicine: Steps to Accelerate Development
Clinical Trial Agreements: A Guide to Key Words and Phrases
Featured Stories
Continual Risk Evaluation Strengthens Systemic CAPA Efforts
Best Practices for Accounting and Auditing
Sites Overwhelmed by Cost and Trial Complexity, Need Sponsor Help to Bear the Burden
Trials Industry to Focus on Patient-Centricity in Next Phase of Pandemic, Executives Predict
New!
2019 Site Survey Reports
Learn More Here
